Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 15 de 15
Filter
Add more filters










Publication year range
1.
J Org Chem ; 66(16): 5317-28, 2001 Aug 10.
Article in English | MEDLINE | ID: mdl-11485450

ABSTRACT

The synthesis of 16a'-homo-leurosidine was achieved through enantioselective generation of a ring D'-seco-precursor 33 (without requirement of a chiral auxiliary). Its cyclization provided the N(b')-quaternary salt 35 with a configuration corresponding to the atropisomeric form 8a rather than 8b of the target product. On debenzylation, the amine 8a was obtained and found not to isomerize thermally to the anticipated atropisomer 8b (in contrast to its lower homologue, with its formation of natural leurosidine). However, on protonation, a 1:1 mixture of atropisomers of 16a'-homo-leurosidine was obtained. A synthesis of 16a'-homo-vinblastine provided two atropisomers 5a and 5b for the free base at equilibrium (1:2.3 at room temperature in CDCl(3)), with a shift to the major conformer 5b with increasing solvent acidity or decreasing temperature. The synthesis was achieved through a stereoselective inversion of the tertiary hydroxyl function in the enantioselectively generated C-20' progenitor 39.


Subject(s)
Alkaloids/chemical synthesis , Antineoplastic Agents, Phytogenic/chemical synthesis , Vinblastine/chemical synthesis , Vinca Alkaloids , Alkaloids/chemistry , Alkaloids/pharmacology , Animals , Antineoplastic Agents, Phytogenic/chemistry , Antineoplastic Agents, Phytogenic/pharmacology , Mice , Molecular Conformation , Tumor Cells, Cultured , Vinblastine/analogs & derivatives , Vinblastine/chemistry , Vinblastine/pharmacology
2.
Immunol Invest ; 22(4): 319-27, 1993 Jun.
Article in English | MEDLINE | ID: mdl-7689536

ABSTRACT

The objective of this study was to determine the effects of nitric oxide (NO) on lymphocyte proliferation and cytokine release. Bronchoalveolar lavage (BAL) cells served as the source of NO and were obtained from rats treated with a single, intratracheal dose of bleomycin (3.6 mg/kg). At the time of sacrifice, the spleens were removed and the lymphocytes separated. Co-cultures containing BAL cells, lymphocytes and concanavalin-A were established and incubated at 37 degrees C for 24 hours at which time proliferation, nitrite concentration and interleukin-2 (IL-2) production were measured. At ratios from 5:1 to 1:4 (BAL:lymphocyte) there was a significant reduction in lymphocyte proliferation. There was a significant, negative correlation between NO concentration and thymidine incorporation which was reversed when the NO synthase inhibitor NG-monomethyl-L-arginine (NMA) was added to the co-cultures. Despite marked inhibition of spleen lymphocyte proliferation by NO, released by BAL cells, there was no corresponding reduction in IL-2 production. These data demonstrate that macrophages, activated in vivo, produce NO which regulates lymphocyte growth but not necessarily functions such as the secretion of the cytokine IL-2. Further, the ability of IL-2-dependent CTLL-2 cells to proliferate in the presence of excess IL-2 was also inhibited by BAL cells, confirming that NO inhibits lymphocyte growth.


Subject(s)
Interleukin-2/metabolism , Lymphocyte Activation/drug effects , Lymphocytes/drug effects , Nitric Oxide/pharmacology , Amino Acid Oxidoreductases/antagonists & inhibitors , Animals , Arginine/analogs & derivatives , Arginine/pharmacology , Cell Division/drug effects , Cells, Cultured , Concanavalin A/pharmacology , Interleukin-1/biosynthesis , Lymphocytes/metabolism , Male , Nitric Oxide Synthase , Rats , Rats, Sprague-Dawley , Spleen/cytology , Spleen/immunology , omega-N-Methylarginine
3.
Soc Work ; 38(3): 281-8, 1993 May.
Article in English | MEDLINE | ID: mdl-8511657

ABSTRACT

Shifts in health concerns, fiscal restraints, technological advances, and demands for accountability have created severe tensions within health care settings. New demands point to the need for a redefinition of services. High-risk screening appears to be a clear method of delineating service need. A review of the empirical literature highlights individual, family, and illness variables that alone and together may improve identification of patients and families in need of social work services. The development of screening mechanisms may be a useful vehicle for improved psychosocial care and for the planning of social work services.


Subject(s)
Family Health , Health Services Needs and Demand/trends , Social Work/trends , Canada , Holistic Health , Home Nursing/psychology , Humans , Referral and Consultation , Risk Factors , Social Support , Stress, Psychological , United States
4.
Health Soc Work ; 17(3): 223-35, 1992 Aug.
Article in English | MEDLINE | ID: mdl-1526602

ABSTRACT

This article describes and analyzes the development of a collaborative research model by one university faculty of social work and 10 health care settings. Established working relationships for educating students were the foundation of a research partnership formed to study questions of mutual interest. This article discusses the developmental stage of the research consortium, including needs assessment, workshop, identification of a common theme and research topic, preliminary funding, and literature review. This stage resulted in the decision to develop and test an instrument to screen for high social risk that would be capable of identifying the need for social work involvement with families to provide effective and efficient management of patients. The Delphi methodology was chosen in the first phase of the research design, and reasons for the choice of this methodology, the results from the two Delphi rounds, and a preliminary screening instrument are presented. Finally, issues in collaboration, such as institutional factors, dynamics of the working group, and leadership roles, are analyzed to identify facilitating features and problematic issues in such partnerships.


Subject(s)
Academies and Institutes , Health Services , Interinstitutional Relations , Research , Social Work , Faculty , Health Services/statistics & numerical data , Humans , Risk Factors , Surveys and Questionnaires
5.
Gene ; 114(2): 165-71, 1992 May 15.
Article in English | MEDLINE | ID: mdl-1601300

ABSTRACT

The ribosomal DNA (rDNA encoding rRNA) of the obligately intracellular protozoan parasite, Toxoplasma gondii, was identified, cloned, physically mapped, its copy number determined, and the 5S gene sequenced. Using total RNA as a probe, a collection of recombinant lambda phages containing copies of rDNA were isolated from a lambda 2001 tachyzoite genomic library. Northern gel hybridization confirmed specific homology of the 7.5-kb rDNA unit, subcloned into pTZ18R, to T. gondii rRNA. The mapped rDNA found in pTOX1 contained small ribosomal subunit (SS; 18S)- and large ribosomal subunit (LS; 26S)-encoding genes localized using intragenic heterologous probes from the conserved sequences of the SS (18S) and LS (28S) Xenopus laevis genes. the physical mapping data, together with partial digestion experiments and Southern gel hybridization, confirmed a 7.5-kb rDNA unit arranged in a simple head-to-tail fashion that is tandemly repeated. We estimated the rDNA repeat copy number in T. gondii to be 110 copies per haploid tachyzoite genome. Parts of the SS gene and the complete 5S gene were sequenced. The 5S gene was found to be within the rDNA locus, a rare occurrence found only in some fungi and protozoa. Secondary-structure analysis revealed an organization remarkably similar to the 5S RNA of eukaryotes.


Subject(s)
DNA, Protozoan , DNA, Ribosomal , RNA, Ribosomal, 5S/genetics , Toxoplasma/genetics , Animals , Base Sequence , Cells, Cultured , Chromosome Mapping , Humans , Molecular Sequence Data , Nucleic Acid Conformation , RNA, Ribosomal, 5S/chemistry , Sequence Alignment , Vero Cells
6.
Immunol Invest ; 21(2): 169-78, 1992 Apr.
Article in English | MEDLINE | ID: mdl-1374736

ABSTRACT

Bleomycin is an important anticancer drug that causes severe, and sometimes life-threatening, pulmonary toxicity. Initially, there is an acute inflammation followed by an irreversible pulmonary fibrosis. Our studies have focussed on the effects of the acute pulmonary inflammation on the state of alveolar macrophage activation. To study this, we administered a single dose of 3.6 mg bleomycin/kg body weight intratracheally to rats and obtained alveolar macrophages at selected times thereafter. Ia expression was determined by fluorescent microscopy of cells labelled with a fluorochrome-tagged antibody against rat Ia molecules. We report that: 1.) alveolar macrophages have elevated Ia expression shortly after receiving intratracheally administered bleomycin; 2.) Ia expression is not limited to a specific subpopulation of alveolar macrophages; 3.) Ia expression is transient in nature returning to control levels 7-14 days after bleomycin administration; and, 4.) the degree of upregulation of Ia expression is directly related to the dose of bleomycin administered.


Subject(s)
Bleomycin/toxicity , Histocompatibility Antigens Class II/metabolism , Macrophages, Alveolar/drug effects , Animals , Bleomycin/administration & dosage , Dose-Response Relationship, Drug , Macrophage Activation/drug effects , Macrophages, Alveolar/immunology , Male , Rats , Rats, Inbred Strains , Trachea , Up-Regulation
7.
Biochem Biophys Res Commun ; 182(1): 151-7, 1992 Jan 15.
Article in English | MEDLINE | ID: mdl-1370609

ABSTRACT

Alveolar macrophages, taken from rats treated with a single intratracheal dose of bleomycin, release reactive nitrogen intermediates in the form of nitric oxide which are cytostatic to murine leukemia L1210 cells. When cultured in the presence of erythrocytes the cytostatic activity of alveolar macrophages was inhibited which corresponded with an increase in nitrosylated hemoglobin content when compared with erythrocytes cultured alone. These results suggest that erythrocytes inhibit alveolar macrophage cytostatic activity by preventing reactive nitrogen intermediates from reaching target cells because the hemoglobin serves as a sink for reactive nitrogen intermediates in the form of nitric oxide.


Subject(s)
Bleomycin/pharmacology , Erythrocytes/physiology , Hemoglobins/metabolism , Macrophages, Alveolar/physiology , Nitric Oxide/metabolism , Animals , Arginine/analogs & derivatives , Arginine/pharmacology , Cell Communication , Cells, Cultured , Erythrocytes/cytology , Inflammation , Leukemia L1210/pathology , Macrophages, Alveolar/cytology , Macrophages, Alveolar/drug effects , Male , Mice , Nitrites/metabolism , Rats , Rats, Inbred Strains , Spectrophotometry , omega-N-Methylarginine
8.
Am J Physiol ; 261(5 Pt 1): E661-4, 1991 Nov.
Article in English | MEDLINE | ID: mdl-1951693

ABSTRACT

A simple mini-butane burner or "artificial rat," for calibration of small animal indirect calorimeters (modified Benedict and Haldane systems), was developed. Substitution of this burner for a live animal at regular intervals in an experimental protocol provides a means by which whole system function can be verified without disturbing respirometer conditions. Heat production, degree of total combustion of butane, proportion of unburned butane, and the CO2 production (VCO2)-to-O2 consumption (VO2) ratio were determined in animal and burner experiments by direct measurement or were derived from mass equations. Burner security was also discussed. VCO2/VO2 obtained in calibration experiments using the Benedict system remained constant and was not significantly different from the expected value for total combustion of butane. Observation of a stabilization phase in the Haldane burner experiments illustrated the utility of calibration over the duration of a normal animal experiment. This miniburner gave highly reproducible results and simulated the daily VO2, VCO2, and heat production of an adult rat.


Subject(s)
Calorimetry, Indirect/instrumentation , Animals , Calibration , Calorimetry, Indirect/methods , Carbon Dioxide/metabolism , Equipment Design , Oxygen Consumption , Temperature
9.
Cancer Res ; 50(24): 7863-6, 1990 Dec 15.
Article in English | MEDLINE | ID: mdl-1701356

ABSTRACT

Bleomycin (BLM) is a useful anticancer agent sometimes associated with a diffuse pulmonary inflammation and fibrosis. Using an intratracheal model of BLM-induced pulmonary damage, we have further investigated alveolar macrophage (AM) activation following intratracheal BLM. From rats that had been treated with either a single, fibrogenic, intratracheal dose of BLM (BLM-AM) or a comparable volume of saline (C-AM), bronchoalveolar lavage fluid was collected, and AM were isolated using Percoll gradient centrifugation. Using a spectrophotometric assay, production of nitrites by AM was measured. C-AM released low levels of nitrites, whereas BLM-AM as well as C-AM activated in vitro with lipopolysaccharide released significant amounts of nitrites. The addition of N6-monomethylarginine, a substrate-specific inhibitor of the L-arginine-dependent effector mechanism in activated macrophages, reduced the amount of measurable nitrites released from both BLM-AM and activated C-AM. Similar results were observed when 12 x 10(6) RBC were added to the cocultures. In the presence of N6-monomethylarginine, BLM-AM had no effect on two consequences of BLM-AM-induced cytostatic activity, DNA synthesis inhibition and aconitase activity reduction in the L1210 target cell. These results suggest that reactive nitrogen intermediates measured as nitrites are important moieties in our in vivo model of macrophage activation. Further, the identification of this effector molecule presents possibilities for therapeutic and biochemical manipulations.


Subject(s)
Bleomycin/toxicity , DNA Replication/drug effects , Lung/pathology , Macrophage Activation/drug effects , Macrophages/immunology , Nitriles/metabolism , Nitrites/metabolism , Aconitate Hydratase/metabolism , Animals , Arginine/analogs & derivatives , Arginine/pharmacology , Cytotoxicity, Immunologic , Kinetics , Leukemia L1210/immunology , Leukemia L1210/metabolism , Lung/drug effects , Macrophages/drug effects , Male , Mice , Rats , Rats, Inbred Strains , Reference Values , omega-N-Methylarginine
10.
Cancer Res ; 50(8): 2351-5, 1990 Apr 15.
Article in English | MEDLINE | ID: mdl-1690596

ABSTRACT

Bleomycin (BLM) has been successfully used to treat a number of human neoplasms. The main toxicity associated with BLM therapy is an acute pulmonary inflammation that can culminate in diffuse chronic fibrosis. The effect of BLM-induced pulmonary inflammation on the cytostatic activity of alveolar macrophages (AM) was investigated using AM obtained from rats that had been previously treated with BLM. Bronchoalveolar lavage fluid was collected at selected time intervals following a single fibrogenic dose of intratracheally administered BLM (3.6 mg/kg). AM obtained 12 to 72 h following intratracheal BLM (BLM-AM) caused cytostasis of murine leukemia L1210 cells in co-culture, whereas AM obtained from saline-treated controls were not cytostatic. These results indicate that the growth-inhibitory activity of the AM was related to the pulmonary inflammation. Cytostatic activity in control AM could be induced by in vitro exposure to lipopolysaccharide (5 micrograms). When RBC were added to the AM-L1210 co-culture, the cytostatic activity of the BLM-AM was abrogated. The fact that chemical treatment of the RBC with sodium nitrite and potassium cyanide or N-ethylmaleimide did not alter the ability of the RBC to abrogate AM cytostatic activity suggests that the RBC is not acting as a scavenger of oxygen radicals. In contrast, the addition of FeSO4 to the AM-L1210 co-culture mimicked the effect of RBC addition. Aconitase, an iron-sulfur-containing enzyme necessary for mitochondrial respiration, is decreased in L1210 cells that have been co-cultured with BLM-AM but not when the co-cultures also contain RBC. These results suggest that (a) pulmonary inflammation induces cytostatic activity in AM, (b) the alteration of iron homeostasis plays an important role in this cytostatic process, and (c) RBC can prevent this cytostatic activity.


Subject(s)
Bleomycin/toxicity , Erythrocytes/physiology , Lung/pathology , Macrophages/physiology , Tumor Cells, Cultured/cytology , Aconitate Hydratase/metabolism , Animals , Cell Survival , Cells, Cultured , DNA Replication , Inflammation , Kinetics , Leukemia L1210/enzymology , Leukemia L1210/pathology , Lung/drug effects , Macrophages/drug effects , Male , Mice , Rats , Rats, Inbred Strains , Tumor Cells, Cultured/enzymology
11.
Mol Cell Probes ; 3(2): 179-88, 1989 Jun.
Article in English | MEDLINE | ID: mdl-2788807

ABSTRACT

Six types of plasmid-mediated carbenicillinases can be distinguished on the basis of their substrate profiles, molecular mass isoelectric values and immunological properties. As yet, no structural classification has been attempted for these enzymes at the molecular level. We have isolated the PSE-4 structural gene responsible for carbenicillinase production in Pseudomonas aeruginosa strain Dalgleish and studied its expression in E. coli. A detailed physical map of the cloned fragment and the construction of deletion mutants permitted the precise localization of the PSE-4 structural gene. Various restriction endonuclease fragments known to be flanking or internal to the PSE-4 bla gene were used as DNA probes and tested for homologous sequences in other beta-lactamase genes. A collection of three restriction fragment probes internal or delimiting the PSE-4 structural gene were hybridized with purified plasmid DNA coding for 18 other beta-lactamases. Under high stringency conditions, only the PSE-1, CARB-3 and CARB-4 genes cross-hybridized with PSE-4; while one of the probes tested hybridized solely with CARB-3. Further analysis indicated that the PSE-1, PSE-4, CARB-3 and CARB-4 bla genes are related and could presumably have evolved from a common progenitor.


Subject(s)
Biological Evolution , DNA Probes , Gram-Negative Bacteria/genetics , Penicillinase/genetics , beta-Lactamases/genetics , DNA, Bacterial/analysis , DNA, Bacterial/genetics , Genes , Molecular Structure , Nucleic Acid Hybridization , Plasmids
SELECTION OF CITATIONS
SEARCH DETAIL